APA (7th ed.) Citation

SK, P., JG, B., & SD, S. (2020). A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine. Expert opinion on drug safety, 19(5), 537. https://doi.org/10.1080/14740338.2020.1737673

Chicago Style (17th ed.) Citation

SK, Parikh, Burkett JG, and Silberstein SD. "A Comprehensive Overview and Safety Evaluation of Fremanezumab as a Preventive Therapy for Migraine." Expert Opinion on Drug Safety 19, no. 5 (2020): 537. https://doi.org/10.1080/14740338.2020.1737673.

MLA (9th ed.) Citation

SK, Parikh, et al. "A Comprehensive Overview and Safety Evaluation of Fremanezumab as a Preventive Therapy for Migraine." Expert Opinion on Drug Safety, vol. 19, no. 5, 2020, p. 537, https://doi.org/10.1080/14740338.2020.1737673.